Washington, DC 20006-5349
HELPLINE
Today, the Meso Foundation wrote a letter to the acting administrator of the EPA urging the agency to account for legacy asbestos when evaluating asbestos risk and the magnitude of the asbestos problem. This letter came as a response to the EPA’s decision to exclude legacy uses of asbestos in its problem formulation. This issue is separate from the recently publicized ‘significant new use rule.’ You can read more here.
EPA_Legacy_Comment_MesoFoundation
On this episode of MesoTV, join our Patient Services Director, Julie White, as she speaks with Marjorie Zauderer, MD, MS, FACP, and Lee Krug, MD,
Dear Members of the Meso Community, We understand the deep concern many of you are feeling regarding the current changes and fluctuations in funding for
Caregivers of mesothelioma patients perform crucial duties and bear considerable burdens after a loved one’s diagnosis of mesothelioma. While resources for patients are often available
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
